- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl) amin
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl) amino] isonicotinamide hydrochloride
| EU orphan designation number: | EU/3/10/824
|
| Active ingredient: | N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl) amino] isonicotinamide hydrochloride |
| Indication: | Treatment of acute myeloid leukaemia |
| Sponsor: | Merck KGaA
Frankfurter Straße 250, D-64293 Darmstadt, Deutschland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 22/12/2010 | Orphan designation | EMA/OD/094/10 | (2010)9537 of 17/12/2010 |
CONTACT
EU links
Directorate General Health & Consumers